Annual EBIT
-$57.13 M
+$1.26 M+2.15%
31 December 2023
Summary:
Milestone Pharmaceuticals annual earnings before interest & taxes is currently -$57.13 million, with the most recent change of +$1.26 million (+2.15%) on 31 December 2023. During the last 3 years, it has fallen by -$6.42 million (-12.66%). MIST annual EBIT is now -590.99% below its all-time high of -$8.26 million.MIST EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$8.54 M
-$60.00 K-0.71%
30 September 2024
Summary:
Milestone Pharmaceuticals quarterly earnings before interest & taxes is currently -$8.54 million, with the most recent change of -$60.00 thousand (-0.71%) on 30 September 2024. Over the past year, it has increased by +$5.70 million (+40.06%). MIST quarterly EBIT is now -1298.88% below its all-time high of $712.00 thousand, reached on 30 June 2021.MIST Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$39.25 M
+$5.70 M+12.69%
30 September 2024
Summary:
Milestone Pharmaceuticals TTM earnings before interest & taxes is currently -$39.25 million, with the most recent change of +$5.70 million (+12.69%) on 30 September 2024. Over the past year, it has increased by +$18.31 million (+31.81%). MIST TTM EBIT is now -822.40% below its all-time high of -$4.25 million, reached on 31 March 2018.MIST TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MIST EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.1% | +40.1% | +31.8% |
| 3 y3 years | -12.7% | +40.2% | -12.4% |
| 5 y5 years | -139.8% | +37.8% | +20.1% |
MIST EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -32.6% | +2.1% | -0.7% | +49.5% | -12.4% | +36.9% |
| 5 y | 5 years | -139.8% | +2.1% | -1298.9% | +54.8% | -19.9% | +38.4% |
| alltime | all time | -591.0% | +2.1% | -1298.9% | +54.8% | -822.4% | +38.4% |
Milestone Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$8.54 M(+0.7%) | -$39.25 M(-12.7%) |
| June 2024 | - | -$8.48 M(-10.6%) | -$44.95 M(-13.1%) |
| Mar 2024 | - | -$9.48 M(-25.7%) | -$51.70 M(-9.5%) |
| Dec 2023 | -$57.13 M(-2.2%) | -$12.75 M(-10.4%) | -$57.13 M(-0.7%) |
| Sept 2023 | - | -$14.24 M(-6.5%) | -$57.56 M(-0.5%) |
| June 2023 | - | -$15.22 M(+2.1%) | -$57.87 M(-2.4%) |
| Mar 2023 | - | -$14.92 M(+13.2%) | -$59.30 M(+1.5%) |
| Dec 2022 | -$58.39 M(+35.6%) | -$13.18 M(-9.5%) | -$58.43 M(-6.0%) |
| Sept 2022 | - | -$14.56 M(-12.6%) | -$62.17 M(+0.5%) |
| June 2022 | - | -$16.65 M(+18.5%) | -$61.89 M(+39.0%) |
| Mar 2022 | - | -$14.05 M(-17.0%) | -$44.53 M(+3.4%) |
| Dec 2021 | -$43.07 M | -$16.92 M(+18.5%) | -$43.07 M(+23.4%) |
| Sept 2021 | - | -$14.27 M(-2104.6%) | -$34.92 M(+6.7%) |
| June 2021 | - | $712.00 K(-105.7%) | -$32.73 M(-29.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$12.59 M(+43.7%) | -$46.55 M(-8.2%) |
| Dec 2020 | -$50.71 M(-12.4%) | -$8.76 M(-27.5%) | -$50.71 M(-16.7%) |
| Sept 2020 | - | -$12.09 M(-7.8%) | -$60.84 M(-2.6%) |
| June 2020 | - | -$13.11 M(-21.8%) | -$62.48 M(-1.9%) |
| Mar 2020 | - | -$16.76 M(-11.3%) | -$63.71 M(+10.1%) |
| Dec 2019 | -$57.88 M(+143.0%) | -$18.89 M(+37.6%) | -$57.88 M(+17.9%) |
| Sept 2019 | - | -$13.72 M(-4.2%) | -$49.10 M(+19.3%) |
| June 2019 | - | -$14.33 M(+31.1%) | -$41.16 M(+34.9%) |
| Mar 2019 | - | -$10.93 M(+8.1%) | -$30.50 M(+28.0%) |
| Dec 2018 | -$23.82 M(+188.1%) | -$10.11 M(+74.7%) | -$23.82 M(+73.7%) |
| Sept 2018 | - | -$5.79 M(+57.4%) | -$13.72 M(+72.9%) |
| June 2018 | - | -$3.68 M(-13.6%) | -$7.93 M(+86.4%) |
| Mar 2018 | - | -$4.25 M | -$4.25 M |
| Dec 2017 | -$8.27 M | - | - |
FAQ
- What is Milestone Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals annual EBIT year-on-year change?
- What is Milestone Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals quarterly EBIT year-on-year change?
- What is Milestone Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals TTM EBIT year-on-year change?
What is Milestone Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of MIST is -$57.13 M
What is the all time high annual EBIT for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high annual earnings before interest & taxes is -$8.26 M
What is Milestone Pharmaceuticals annual EBIT year-on-year change?
Over the past year, MIST annual earnings before interest & taxes has changed by +$1.26 M (+2.15%)
What is Milestone Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of MIST is -$8.54 M
What is the all time high quarterly EBIT for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high quarterly earnings before interest & taxes is $712.00 K
What is Milestone Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, MIST quarterly earnings before interest & taxes has changed by +$5.70 M (+40.06%)
What is Milestone Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of MIST is -$39.25 M
What is the all time high TTM EBIT for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high TTM earnings before interest & taxes is -$4.25 M
What is Milestone Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, MIST TTM earnings before interest & taxes has changed by +$18.31 M (+31.81%)